Search
Indium In-111
go.drugbank.com/drugs/DB11916InvestigationalIndium In-111 is under investigation in clinical trial NCT00493454 (Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas).
Synonyms: Indium In-111, Indium (111 In)Caficrestat
go.drugbank.com/drugs/DB15121InvestigationalAT-001 is under investigation in clinical trial NCT03062384 (AT-001 for Long-term Preservation of Brain Health in Aging).
Bfpet F-18
go.drugbank.com/drugs/DB15424InvestigationalBfpet F-18 is under investigation in clinical trial NCT03265431 (Evaluation of PET/MR in Patients Selected for Ablation Therapy).
Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester
go.drugbank.com/drugs/DB01774ExperimentalServes as the glycosyl donor for formation of bacterial glycogen, amylose in green algae, and amylopectin in higher plants. [PubChem]
Azelnidipine
go.drugbank.com/drugs/DB09230InvestigationalIt has a gradual onset of action and produces a long-lasting decrease in blood pressure, with only a small increase in heart rate, unlike some other calcium channel blockers [L1379]. … It is currently being studied for post-ischemic stroke management [L1380].
International brands: Rezaltas LDRocapuldencel-T
go.drugbank.com/drugs/DB17588InvestigationalRocapuldencel-T is an autologous dendritic cell immunotherapy that was investigated in NCT02662634 (A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
Guanabenz
go.drugbank.com/drugs/DB00629ApprovedWithdrawnGuanabenz is an alpha-2 selective adrenergic agonist used as an antihypertensive agent.
Synonyms: N-(2,6-DICHLOROBENZYLIDENE)-N'-AMIDINOHYDRAZINEMarine collagen, soluble
go.drugbank.com/drugs/DB14246InvestigationalMarine collagen, soluble is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.
Mixtures: NutraVita MARINE COLLAGEN + ALA CapsuleNeltenexine
go.drugbank.com/drugs/DB13239InvestigationalNeltenexine is an elastase inhibitor. It may be useful for preventing pulmonary emphysema.
VO659
go.drugbank.com/drugs/DB18160InvestigationalVO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.
Synonyms: an antisense oligonucleotide that has been developed to target expanded CAG repeats in messenger ribonucleic acid (mRNA)